Best for 0% commission stocks
Capital at risk. Fees apply. T&Cs apply
- Commission-free trades
- Fractional shares
- Free to open an account
A subsidiary of Johnson & Johnson, Janssen is a Belgian pharmaceutical company which announced in January 2021 that its single-dose COVID-19 vaccine is 66% effective. As a single-dose jab, the vaccine would be easier to roll out than existing vaccines, and could help boost the international vaccination effort. While the vaccine has yet to be approved by regulators, the UK has already pre-ordered 30 million doses.
Janssen Pharmaceuticals is a pharmaceutical company that researches medical disorders, such as mental illness, neurological disorders and gastrointestinal disorders, for the development of new drugs. Janssen is one of the companies that has created a vaccine for COVID-19, having received $456 million (£342 million) from the U.S. Biomedical Advanced Research and Development Authority.
It’s possible to invest in Janssen Pharmaceuticals, but as it’s owned by Johnson & Johnson, you’d need to buy Johnson & Johnson shares.
This means that if you choose to invest in Janssen by buying shares in Johnson & Johnson, then you’ll be investing in the other brands that it owns as well. Research all of the brands above and other brands that Johnson & Johnson owns to get a full picture of the company.
Best for 0% commission stocks
Capital at risk. Fees apply. T&Cs apply
Best for active investing
Capital at risk. T&Cs apply
Best for US shares
Capital at risk
| Open | $N/A | Previous close | $N/A |
| High | $N/A | Change | $N/A |
| Low | $N/A | Change % | N/A% |
| Close | $N/A | Timestamp | 1970-01-01 |
| Volume | N/A | GMT offset | N/A |
| Industry | Drug Manufacturers - General | Currency symbol | $ |
| Code | JNJ | Country name | USA |
| Type | Common Stock | Country ISO | US |
| Name | Johnson & Johnson | ISIN | N/A |
| Exchange | NYSE | CUSIP | N/A |
| Currency code | USD | Sector | Healthcare |
| Currency name | US Dollar | Full-time employees | 138200 |
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Looking for other options? Check out these similar products.
How we picked theseTo make comparing even easier we came up with the Finder Score. Costs, features, ease and range of investments across 30+ platforms are all weighted and scaled to produce a score out of 10. The higher the score the better the platform – simple.
Read the full methodologyJanssen was founded in 1953 and has produced a huge range of drugs, including 8 that are included in the World Health Organisation’s Model List of Essential Medicines. It’s one of the companies that’s created a vaccine against coronavirus, which has been approved in several countries, including the UK.
Johnson & Johnson owns some of the most recognisable brands in the healthcare aisle in the supermarket. If you’re umming and ahhing between two facial washes, there’s a pretty good chance they’re both made by Johnson & Johnson.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Alex Gorsky is the CEO of Johnson & Johnson.
Janssen Pharmaceuticals was acquired by Johnson & Johnson in October 1961.
Find out the best care home shares along with the pros and cons of investing in this grey-pound-fuelled sector.
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.
Ever wondered how to buy shares in Eli Lilly and Company? We explain how to invest in Eli Lilly in the UK along with platforms for buying stock.
How to buy shares in Pfizer
Ever wondered how to buy shares in AstraZeneca? We explain how and compare a range of providers that can give you access to many brands, including AstraZeneca.
Learn more about GSK’s recent performance and where you can buy GSK shares. We also run through a helpful checklist for anyone looking to invest.
We are an independent comparison platform and information service designed to help you make better decisions. To keep our service free, we receive compensation from the companies whose products or services are featured on our site. We may receive payment when you click on links or apply for products through our platform.
While our commercial arrangements may affect the inclusion, order, position and placement of products on our site, they do not influence our independent assessments or editorial views. The inclusion of a provider or product in content or the order in which products are displayed in tables or lists should not be interpreted as a specific endorsement or recommendation from us.
We compare a wide range of products, providers, and services, but we do not cover the whole market. There may be other options available to you outside of our platform.
The information we provide does not constitute financial advice. You should consider your own personal circumstances and read the provider's terms and conditions before making a decision.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.